Skip to main navigation Skip to search Skip to main content

A Multicenter, Open Label Study to Evaluate the Safety of Entocort TM EC for the Treatment of Crohn's Disease in Pediatric Subjects Aged 5 to 17 Years, Inclusive

Project: Research

Project Details

StatusFinished
Effective start/end date01/23/12 → 02/1/15

Funding

  • AstraZeneca Pharmaceuticals LP: $55,605.12